Farther Finance Advisors, LLC Harmony Biosciences Holdings, Inc. Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 636 shares of HRMY stock, worth $21,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
636
Previous 18
3433.33%
Holding current value
$21,643
Previous $496,000
4698.19%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HRMY
# of Institutions
319Shares Held
44MCall Options Held
1.05MPut Options Held
310K-
Black Rock Inc. New York, NY5.84MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.81MShares$164 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.69MShares$57.6 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.67MShares$56.8 Million0.02% of portfolio
-
State Street Corp Boston, MA1.65MShares$56.3 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.01B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...